Outcomes of the veterans affairs lowvision intervention trial II (lovit II) a randomized clinical trial

Joan A. Stelmack, X. Charlene Tang, Yongliang Wei, Denise Thomas Wilcox, Timothy Morand, Karen Brahm, Scott Sayers, Robert W. Massof

Research output: Contribution to journalArticlepeer-review


IMPORTANCE Randomized clinical trials are needed to compare effectiveness and cost-effectiveness of different low-vision (LV) programs. OBJECTIVE To determine the value of adding LV rehabilitation with a therapist compared with LV services without intervention. DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trialwas conducted from September 27, 2010, to July 31, 2014, of 323 veterans with macular diseases and best-corrected distance visual acuity (BCDVAbetter-eye) of 20/50 to 20/200. Masked interviewers administered questionnaires by telephone before and after LV treatment. Using an intention-to-treat design, participants were randomized to receive LV devices with no therapy or LV devices with a rehabilitation therapist providing instruction and homework on the use of LV devices, eccentric viewing, and environmental modification. Visual ability was measured in dimensionless log odds units (logits) (0.14-logit change in visual ability corresponds to ability change expected from a 1-line change in visual acuity). INTERVENTIONS Low-vision devices without therapy and LV devices with therapy. MAIN OUTCOMES AND MEASURES Comparison of changes (baseline to 4 months) in overall visual ability and in 4 functional domains (reading, visual information, visual motor, and mobility) estimated from responses to the Veterans Affairs Low Vision Visual Functioning Questionnaire (higher scores indicates more ability or less difficulty in performing activities), and comparison of MNREAD changes (baseline to end of treatment) in maximum reading speed, critical print size, and reading acuity (higher number indicates lower visual acuity). RESULTS Of the 323 participants, 314were male (97.2%); mean (SD) age, 80 (10.5) years. Basic LVwas effective in improving visual ability. However, the LV rehabilitation group improved more in all visual function domains except mobility. Differenceswere 0.34-logit reading (95%CI, 0.0005 to 0.69; P = .05), 0.27-logit visual information (95%CI, 0.01 to 0.53; P = .04), 0.37-logit visual motor (95%CI, 0.08 to 0.66; P = .01), and 0.27-logit overall (95%CI, 0.06 to 0.49; P = .01). For MNREAD measures, therewas more improvement in reading acuity (difference, ?0.11 logMAR, 95%CI, ?0.15 to ?0.07; P < .001) and maximum reading speed (mean increase of 21.0words/min; 95%CI, 6.4 to 35.5; P = .005), but not critical print size for the LV rehabilitation group (?0.06 logMAR; 95%CI, ?0.12 to 0.002; P = .06). In stratified analyses, the LV rehabilitation group with BCDVAbetter-eyeworse than 20/63 to 20/200 improved more in visual ability (reading, visual motor, and overall). Differenceswere 0.56-logit reading ability (95%CI, 0.08-1.04; P = .02), 0.40-logit visual motor (95%CI, 0.03-0.78; P = .04), 0.34-logit overall (95%CI, 0.06-0.62; P = .02). Therewas no significant difference between treatment groups for those with BCDVAbetter-eye of 20/50 to 20/63. CONCLUSIONS AND RELEVANCE Both basic LV alone and combined with LV rehabilitation were effective, but the added LV rehabilitation increased the effect only for patients with BCDVAbetter-eye worse than 20/63 to 20/200. Basic LV servicesmay be sufficient for most LV patients with mild visual impairment.

Original languageEnglish (US)
Pages (from-to)96-104
Number of pages9
JournalJAMA ophthalmology
Issue number2
StatePublished - Feb 1 2017
Externally publishedYes

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Outcomes of the veterans affairs lowvision intervention trial II (lovit II) a randomized clinical trial'. Together they form a unique fingerprint.

Cite this